Codman Enterprise 2 Intracranial Vascular Reconstruction Device Launched in Europe

April 27, 2015—Codman Neuro announced the European launch of the Codman Enterprise 2 vascular reconstruction device, which is the next generation of the company’s self-expanding stent and delivery system used to treat wide-necked intracranial aneurysms and to help maintain the position of endovascular coils. Codman Neuro is a part of the DePuy Synthes Companies of Johnson & Johnson.

Jan-Hendrik Buhk, MD, was the first interventional neuroradiologist in the Europe-Middle East-Africa region to use the technology. In Codman Neuro’s announcement, Dr. Buhk commented, “The Enterprise 2 system provided me with predictable positioning, intraoperative control, and stability once in place and fully met my expectations of a remodeling stent.” Dr. Buhk is from University Medical Center, Hamburg Eppendorf, in Hamburg, Germany.

According to the company, the Codman Enterprise 2 system is designed to improve vessel wall conformability in tortuous anatomy while maintaining its ability to provide a stable structure at the neck of an aneurysm, securing the placement of coils, and maintaining blood flow through the artery. The next-generation stent is more visible under fluoroscopy than the previous device and comes with device enhancements that make it easier for physicians to deploy during the procedure. The first-generation device was introduced in 2006, noted Codman Neuro.